Radioimmunotherapy

Overview

Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Radioimmunotherapy

Topic type

Treatment

Category

Therapy

MeSH classification

E02.095.465.425.750|E02.186.750|E02.815.520

Questions to ask about Radioimmunotherapy

• What outcome should I realistically expect?
• How many appointments or sessions may be needed?
• Are there alternative treatment options?
• What are the possible risks or side effects?
• What follow-up care may be required?

Finding care related to Radioimmunotherapy

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.